Targeting of low-dose CT screening according to the risk of lung-cancer death.

BACKGROUND In the National Lung Screening Trial (NLST), screening with low-dose computed tomography (CT) resulted in a 20% reduction in lung-cancer mortality among participants between the ages of 55 and 74 years with a minimum of 30 pack-years of smoking and no more than 15 years since quitting. It is not known whether the benefits and potential harms of such screening vary according to lung-cancer risk. METHODS We assessed the variation in efficacy, the number of false positive results, and the number of lung-cancer deaths prevented among 26,604 participants in the NLST who underwent low-dose CT screening, as compared with the 26,554 participants who underwent chest radiography, according to the quintile of 5-year risk of lung-cancer death (ranging from 0.15 to 0.55% in the lowest-risk group [quintile 1] to more than 2.00% in the highest-risk group [quintile 5]). RESULTS The number of lung-cancer deaths per 10,000 person-years that were prevented in the CT-screening group, as compared with the radiography group, increased according to risk quintile (0.2 in quintile 1, 3.5 in quintile 2, 5.1 in quintile 3, 11.0 in quintile 4, and 12.0 in quintile 5; P=0.01 for trend). Across risk quintiles, there were significant decreasing trends in the number of participants with false positive results per screening-prevented lung-cancer death (1648 in quintile 1, 181 in quintile 2, 147 in quintile 3, 64 in quintile 4, and 65 in quintile 5). The 60% of participants at highest risk for lung-cancer death (quintiles 3 through 5) accounted for 88% of the screening-prevented lung-cancer deaths and for 64% of participants with false positive results. The 20% of participants at lowest risk (quintile 1) accounted for only 1% of prevented lung-cancer deaths. CONCLUSIONS Screening with low-dose CT prevented the greatest number of deaths from lung cancer among participants who were at highest risk and prevented very few deaths among those at lowest risk. These findings provide empirical support for risk-based targeting of smokers for such screening. (Funded by the National Cancer Institute.).

[1]  C. Henschke,et al.  Computed Tomography Screening for Lung Cancer , 2013, Annals of Internal Medicine.

[2]  S W Duffy,et al.  Clinical Studies , 1877, Journal of Psychological Medicine and Mental Pathology (London, England : 1875).

[3]  C. Begg,et al.  Variations in lung cancer risk among smokers. , 2003, Journal of the National Cancer Institute.

[4]  D. Lynch,et al.  The National Lung Screening Trial: overview and study design. , 2011, Radiology.

[5]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[6]  S. Thompson,et al.  How should meta‐regression analyses be undertaken and interpreted? , 2002, Statistics in medicine.

[7]  S. Duffy,et al.  Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer , 2012, Annals of Internal Medicine.

[8]  J. Jett,et al.  Screening for Lung Cancer: For Patients at Increased Risk for Lung Cancer, It Works , 2011, Annals of Internal Medicine.

[9]  G. Silvestri.  Screening for Lung Cancer: It Works, but Does It Really Work? , 2011, Annals of Internal Medicine.

[10]  J Benichou,et al.  Estimates of absolute cause-specific risk in cohort studies. , 1990, Biometrics.

[11]  B. Stricker,et al.  Generalizing lung-cancer screening results. , 2012, The New England journal of medicine.

[12]  H. Sox.  Better evidence about screening for lung cancer. , 2011, The New England journal of medicine.

[13]  Matthew B Schabath,et al.  A risk model for prediction of lung cancer. , 2007, Journal of the National Cancer Institute.

[14]  M. Gould,et al.  When the Average Applies to No One: Personalized Decision Making About Potential Benefits of Lung Cancer Screening , 2012, Annals of Internal Medicine.

[15]  Timothy R Church,et al.  Selection criteria for lung-cancer screening. , 2013, The New England journal of medicine.

[16]  A. Malarcher,et al.  Cigarette smoking among adults and trends in smoking cessation - United States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[17]  G. Colditz,et al.  Online Continuing Education Activity Article Title: American Cancer Society Lung Cancer Screening Guidelines Continuing Medical Education Accreditation and Designation Statement: Continuing Nursing Education Accreditation and Designation Statement: Educational Objectives: Activity Disclosures Acs Co , 2022 .

[18]  Jeannine S. Schiller,et al.  Early release of selected estimates based on data from the January-March 2011 National Health Interview Survey , 2011 .

[19]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[20]  R. Tibshirani.  The lasso method for variable selection in the Cox model. , 1997, Statistics in medicine.

[21]  Heber MacMahon,et al.  The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. , 2012, The Journal of thoracic and cardiovascular surgery.

[22]  Jeremy MG Taylor,et al.  Validation of Biomarker-Based Risk Prediction Models , 2008, Clinical Cancer Research.

[23]  E. Quoix,et al.  From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF) , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  Steven Peace,et al.  Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. , 2005, Journal of the National Cancer Institute.

[25]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[26]  P. Prorok,et al.  Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. , 2011, Journal of the National Cancer Institute.

[27]  Massimo Bellomi,et al.  Lung Cancer Risk Prediction to Select Smokers for Screening CT—a Model Based on the Italian COSMOS Trial , 2011, Cancer Prevention Research.

[28]  M. Lock,et al.  Computed tomographic screening for lung cancer. , 2007, Canadian family physician Medecin de famille canadien.

[29]  C. Berg,et al.  Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? , 2012, Journal of medical screening.

[30]  Denise R. Aberle,et al.  Baseline Characteristics of Participants in the Randomized National Lung Screening Trial , 2010, Journal of the National Cancer Institute.

[31]  Hiroto Hatabu,et al.  Lung cancer screening, radiation, risks, benefits, and uncertainty. , 2012, JAMA.

[32]  Matthew B Schabath,et al.  Lung cancer screening. , 2003, Journal of the National Comprehensive Cancer Network : JNCCN.

[33]  Ella A. Kazerooni,et al.  Lung cancer screening: Clinical practice guidelines in oncology , 2012 .